Recce Pharmaceuticals Ltd
ASX:RCE
Recce Pharmaceuticals Ltd
Cash from Operating Activities
Recce Pharmaceuticals Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Recce Pharmaceuticals Ltd
ASX:RCE
|
Cash from Operating Activities
AU$3.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Cash from Operating Activities
-AU$42.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Cash from Operating Activities
AU$184.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
96%
|
CAGR 10-Years
N/A
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Cash from Operating Activities
-AU$10.1m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-29%
|
|
Probiotec Ltd
ASX:PBP
|
Cash from Operating Activities
AU$15.7m
|
CAGR 3-Years
17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
9%
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Cash from Operating Activities
-AU$27.5m
|
CAGR 3-Years
-59%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Recce Pharmaceuticals Ltd's Cash from Operating Activities?
Cash from Operating Activities
3.7m
AUD
Based on the financial report for Dec 31, 2023, Recce Pharmaceuticals Ltd's Cash from Operating Activities amounts to 3.7m AUD.